大型预付健康计划中接受治疗的终末期肾病的流行病学特征。
Epidemiologic features of treated end-stage renal disease in a large prepaid health plan.
作者信息
Ordonez J D, Hiatt R A, Quesenberry C P
机构信息
Department of Medicine, Kaiser Permanente Medical Center, Oakland, CA 94611-5693.
出版信息
Am J Public Health. 1990 Jan;80(1):47-9. doi: 10.2105/ajph.80.1.47.
Abstract
We examined the incidence of treated end-stage renal disease (ESRD) among the two million members of the Kaiser Permanente Medical Care Program of Northern California from 1973 through 1985. The age-adjusted incidence rates rose from 33.9 to 81.7 per million person-years and showed no signs of stabilization. Rates were higher in men than in women and rose with age. Marked upward trends (p less than .001) in the rates of treated ESRD associated with diabetic nephropathy and hypertension were noted.
摘要
我们调查了1973年至1985年期间北加利福尼亚州凯撒医疗保健计划的200万成员中接受治疗的终末期肾病（ESRD）的发病率。年龄调整后的发病率从每百万人年33.9例上升至81.7例，且没有稳定的迹象。男性的发病率高于女性，且随年龄增长而上升。观察到与糖尿病肾病和高血压相关的接受治疗的ESRD发病率有显著上升趋势（p<0.001）。
相似文献
1
Epidemiologic features of treated end-stage renal disease in a large prepaid health plan.大型预付健康计划中接受治疗的终末期肾病的流行病学特征。
Am J Public Health. 1990 Jan;80(1):47-9. doi: 10.2105/ajph.80.1.47.
2
Characteristics of patients referred for treatment of end-stage renal disease in a defined population.特定人群中因终末期肾病接受治疗的患者特征。
Am J Public Health. 1982 Aug;72(8):829-33. doi: 10.2105/ajph.72.8.829.
3
Comparison of type II and type I diabetics treated for end-stage renal disease in a large prepaid health plan population.
Nephron. 1989;51(4):524-9. doi: 10.1159/000185387.
4
[Incidence of end-stage renal disease in Ile de France: a prospective epidemiological survey].[法兰西岛地区终末期肾病的发病率：一项前瞻性流行病学调查]
Presse Med. 2000 Mar 25;29(11):589-92.
5
Interpreting incidence trends for treated end-stage renal disease: implications for evaluating disease control in Australia.解读接受治疗的终末期肾病的发病率趋势：对评估澳大利亚疾病控制情况的启示
Nephrology (Carlton). 2004 Aug;9(4):238-46. doi: 10.1111/j.1440-1797.2004.00259.x.
6
Trends in incidence of treated end-stage renal disease, overall and by primary renal disease, in persons aged 20-64 years in Europe, Canada and the Asia-Pacific region, 1998-2002.1998 - 2002年欧洲、加拿大及亚太地区20 - 64岁人群中接受治疗的终末期肾病发病率趋势，总体及按原发性肾病分类的发病率趋势
Nephrology (Carlton). 2007 Oct;12(5):520-7. doi: 10.1111/j.1440-1797.2007.00830.x.
7
8
Trends in incidence of end-stage renal disease in Japan, 1983-2000: age-adjusted and age-specific rates by gender and cause.1983 - 2000年日本终末期肾病发病率趋势：按性别和病因划分的年龄调整率和特定年龄率。
Nephrol Dial Transplant. 2004 Aug;19(8):2044-52. doi: 10.1093/ndt/gfh317. Epub 2004 Jun 1.
9
Elevated blood pressure and risk of end-stage renal disease in subjects without baseline kidney disease.无基线肾病受试者的血压升高与终末期肾病风险
Arch Intern Med. 2005 Apr 25;165(8):923-8. doi: 10.1001/archinte.165.8.923.
10
Geographic, ethnic, age-related and temporal variation in the incidence of end-stage renal disease in Europe, Canada and the Asia-Pacific region, 1998-2002.1998 - 2002年欧洲、加拿大及亚太地区终末期肾病发病率的地理、种族、年龄相关及时间变化
Nephrol Dial Transplant. 2006 Aug;21(8):2178-83. doi: 10.1093/ndt/gfl145. Epub 2006 Apr 4.
引用本文的文献
1
End-stage renal disease and race: an overview and perspective.终末期肾病与种族：概述与展望
J Natl Med Assoc. 1991 Sep;83(9):794-8.
本文引用的文献
1
The Medicare experience with end-stage renal disease: trends in incidence, prevalence, and survival.医疗保险在终末期肾病方面的情况：发病率、患病率及生存率的趋势
Health Care Financ Rev. 1984 Spring;5(3):69-88.
2
Characteristics of patients referred for treatment of end-stage renal disease in a defined population.特定人群中因终末期肾病接受治疗的患者特征。
Am J Public Health. 1982 Aug;72(8):829-33. doi: 10.2105/ajph.72.8.829.
3
Does obesity explain excess prevalence of diabetes among Mexican Americans? Results of the San Antonio Heart Study.肥胖能否解释墨西哥裔美国人中糖尿病的高患病率？圣安东尼奥心脏研究结果。
Diabetologia. 1983 Apr;24(4):272-7. doi: 10.1007/BF00282712.
4
The incidence of treated end stage renal disease in the eastern United States: 1973-1979.美国东部地区经治疗的终末期肾病发病率：1973 - 1979年
Am J Public Health. 1984 Jan;74(1):14-7. doi: 10.2105/ajph.74.1.14.
5
The recent U.S. experience in the treatment of end-stage renal disease by dialysis and transplantation.
N Engl J Med. 1983 Jun 30;308(26):1558-63. doi: 10.1056/NEJM198306303082603.
6
The frequency of kidney and urinary tract diseases in a defined population.
Kidney Int. 1982 Jul;22(1):63-8. doi: 10.1038/ki.1982.133.
7
End-stage renal disease in Michigan. Incidence, underlying causes, prevalence, and modalities of treatment.密歇根州的终末期肾病。发病率、潜在病因、患病率及治疗方式。
Am J Nephrol. 1985;5(2):84-95. doi: 10.1159/000166912.
8
Epidemiologic approach to the etiology of type I diabetes mellitus and its complications.1型糖尿病及其并发症病因的流行病学研究方法。
N Engl J Med. 1987 Nov 26;317(22):1390-8. doi: 10.1056/NEJM198711263172206.
9
Racial factors in the incidence and causation of end-stage renal disease (ESRD).终末期肾病（ESRD）发病率及病因中的种族因素。
Trans Am Soc Artif Intern Organs. 1977;23:28-33. doi: 10.1097/00002480-197700230-00008.
10
An areawide survey of treated end-stage renal disease.经治疗的终末期肾病的全区域调查。
Am J Public Health. 1978 Feb;68(2):166-9. doi: 10.2105/ajph.68.2.166.
Zotero 插件